Next endoscopic approach for acute lower gastrointestinal bleeding without an identified source on colonoscopy: upper or capsule endoscopy?

Abstract

Background and study aims We evaluated the utility of esophagogastroduodenoscopy (EGD) or capsule endoscopy (CE) as the next diagnostic approach after negative colonoscopy (CS) results in acute-onset hematochezia.

Patients and methods We retrospectively analyzed 401 patients emergently hospitalized for acute hematochezia who underwent CS within 48 hours of arriving at two large emergency hospitals and in whom a definitive bleeding source was not identified. The positive endoscopic findings, requirement for additional therapeutic procedures, and 30-day rebleeding rates were compared among three strategies: EGD following CS (CS-EGD), CE following CS (CS-CE), and CS alone. Predictors of positive endoscopic findings in the CS-EGD strategy were determined.

Results The rates of positive endoscopic findings and requirement for additional therapeutic procedures were 22 % and 16 %, respectively, in CS-EGD and 50 % and 28 % in CS-CE. The 30-day rebleeding rate did not significantly decrease in CS-EGD (8 %) or CS-CE (11 %) compared with CS alone (12 %). The rate of additional endoscopic therapies was lower in patients with a colonic diverticulum than in those without (CS-EGD: 3 % vs. 33 %, P = 0.007; CS-CE: 11 % vs. 44 %, P = 0.147). A history of syncope, low blood pressure, blood urea nitrogen/creatinine ratio of ≥ 30, and low albumin level significantly predicted EGD findings after negative CS results (P < 0.05).

Conclusions When the definitive bleeding source is not identified by colonoscopy in patients with acute hematochezia, adjunctive endoscopy helps to identify the etiology and enables subsequent therapy, especially for patients without a colonic diverticulum. Upper gastrointestinal endoscopy is indicated for severe bleeding; other patients may be candidates for capsule endoscopy.

• References

• 1 Gralnek IM, Dumonceau JM, Kuipers EJ. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2015; 47: a1-46
• 2 Strate LL, Gralnek IM. ACG clinical guideline: Management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol 2016; 111: 459-474
• 3 Schlag C, Menzel C, Nennstiel S. et al. Emergency video capsule endoscopy in patients with acute severe GI bleeding and negative upper endoscopy results. Gastrointest Endosc 2015; 81: 889-895
• 4 Green BT, Rockey DC, Portwood G. et al. Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: A randomized controlled trial. Am J Gastroenterol 2005; 100: 2395-2402
• 5 Laine L, Shah A. Randomized trial of urgent vs. elective colonoscopy in patients hospitalized with lower GI bleeding. Am J Gastroenterol 2010; 105: 2636-2641 ; quiz 2642
• 6 Gralnek IM, Neeman Z, Strate LL. Acute lower gastrointestinal bleeding. NEJM 2017; 376: 1054-1063
• 7 Jansen A, Harenberg S, Grenda U. et al. Risk factors for colonic diverticular bleeding: A westernized community based hospital study. World J Gastroenterol 2009; 15: 457-461
• 8 Strate LL, Syngal S. Timing of colonoscopy: Impact on length of hospital stay in patients with acute lower intestinal bleeding. Am J Gastroenterol 2003; 98: 317-322
• 9 Smoot RL, Gostout CJ, Rajan E. et al. Is early colonoscopy after admission for acute diverticular bleeding needed?. Am J Gastroenterol 2003; 98: 1996-1999
• 10 Suzuki K, Uchiyama S, Imajyo K. et al. Risk factors for colonic diverticular hemorrhage: Japanese multicenter study. Digestion 2012; 85: 261-265
• 11 Yamada A, Sugimoto T, Kondo S. et al. Assessment of the risk factors for colonic diverticular hemorrhage. Dis Colon Rectum 2008; 51: 116-120
• 12 Tanaka Y, Motomura Y, Akahoshi K. et al. Predictive factors for colonic diverticular rebleeding: A retrospective analysis of the clinical and colonoscopic features of 111 patients. Gut Liver 2012; 6: 334-338
• 13 Pasha SF, Shergill A. ASGE Standards of Practice Committee. et al. The role of endoscopy in the patient with lower GI bleeding. Gastrointest Endosc 2014; 79: 875-885
• 14 Aoki T, Nagata N, Shimbo T. et al. Development and validation of a risk scoring system for severe acute lower gastrointestinal bleeding. Clin Gastroenterol Hepatol 2016; 14: 1562-1570.e2
• 15 Nagata N, Niikura R, Aoki T. et al. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy. Gastrointest Endosc 2014; 80: 1124-1131
• 16 Nagata N, Niikura R, Yamada A. et al. Acute middle gastrointestinal bleeding risk associated with NSAIDs, antithrombotic drugs, and PPIs: A multicenter case-control study. PLoS One 2016; 11: e0151332
• 17 Singh A, Marshall C, Chaudhuri B. et al. Timing of video capsule endoscopy relative to overt obscure GI bleeding: Implications from a retrospective study. Gastrointest Endosc 2013; 77: 761-766
• 18 Albert J, Gobel CM, Lesske J. et al. Simethicone for small bowel preparation for capsule endoscopy: A systematic, single-blinded, controlled study. Gastrointest Endosc 2004; 59: 487-491
• 19 Yamada A, Watabe H, Kobayashi Y. et al. Timing of capsule endoscopy influences the diagnosis and outcome in obscure-overt gastrointestinal bleeding. Hepatogastroenterology 2012; 59: 676-679
• 20 Charlson M, Szatrowski TP, Peterson J. et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251
• 21 Gerson LB, Fidler JL, Cave DR. et al. ACG clinical guideline: Diagnosis and management of small bowel bleeding. Am J Gastroenterol 2015; 110: 1265-1287 ; quiz 1288
• 22 Prakash C, Zuckerman GR. Acute small bowel bleeding: A distinct entity with significantly different economic implications compared with GI bleeding from other locations. Gastrointest Endosc 2003; 58: 330-335